Advertisement

Ads Placeholder
Loading...

CapsoVision, Inc.

CVNASDAQ
Healthcare
Medical - Equipment & Services
$7.44
$0.79(11.88%)
U.S. Market opens in 57h 31m

CapsoVision, Inc. Fundamental Analysis

CapsoVision, Inc. (CV) shows moderate financial fundamentals with a PE ratio of -72.17, profit margin of -1.87%, and ROE of 1.05%. The company generates $0.0B in annual revenue with strong year-over-year growth of 20.54%.

Key Strengths

PEG Ratio0.46
Current Ratio3.77

Areas of Concern

ROE1.05%
Operating Margin1.66%
Cash Position0.55%
We analyze CV's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -70.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-70.9/100

We analyze CV's fundamental strength across five key dimensions:

Efficiency Score

Weak

CV struggles to generate sufficient returns from assets.

ROA > 10%
-1.39%

Valuation Score

Excellent

CV trades at attractive valuation levels.

PE < 25
-72.17
PEG Ratio < 2
0.46

Growth Score

Moderate

CV shows steady but slowing expansion.

Revenue Growth > 5%
20.54%
EPS Growth > 10%
0.00%

Financial Health Score

Excellent

CV maintains a strong and stable balance sheet.

Debt/Equity < 1
0.07
Current Ratio > 1
3.77

Profitability Score

Weak

CV struggles to sustain strong margins.

ROE > 15%
105.09%
Net Margin ≥ 15%
-1.87%
Positive Free Cash Flow
No

Key Financial Metrics

Is CV Expensive or Cheap?

P/E Ratio

CV trades at -72.17 times earnings. This suggests potential undervaluation.

-72.17

PEG Ratio

When adjusting for growth, CV's PEG of 0.46 indicates potential undervaluation.

0.46

Price to Book

The market values CapsoVision, Inc. at 137.78 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

137.78

EV/EBITDA

Enterprise value stands at -12.73 times EBITDA. This is generally considered low.

-12.73

How Well Does CV Make Money?

Net Profit Margin

For every $100 in sales, CapsoVision, Inc. keeps $-1.87 as profit after all expenses.

-1.87%

Operating Margin

Core operations generate 1.66 in profit for every $100 in revenue, before interest and taxes.

1.66%

ROE

Management delivers $1.05 in profit for every $100 of shareholder equity.

1.05%

ROA

CapsoVision, Inc. generates $-1.39 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.39%

Following the Money - Real Cash Generation

Operating Cash Flow

CapsoVision, Inc. generates limited operating cash flow of $-5.65M, signaling weaker underlying cash strength.

$-5.65M

Free Cash Flow

CapsoVision, Inc. generates weak or negative free cash flow of $-5.68M, restricting financial flexibility.

$-5.68M

FCF Per Share

Each share generates $-0.11 in free cash annually.

$-0.11

FCF Yield

CV converts -7.55% of its market value into free cash.

-7.55%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-72.17

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.46

vs 25 benchmark

P/B Ratio

Price to book value ratio

137.78

vs 25 benchmark

P/S Ratio

Price to sales ratio

27.36

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.07

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.77

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

1.05

vs 25 benchmark

ROA

Return on assets percentage

-1.39

vs 25 benchmark

ROCE

Return on capital employed

0.02

vs 25 benchmark

How CV Stacks Against Its Sector Peers

MetricCV ValueSector AveragePerformance
P/E Ratio-72.1728.45 Better (Cheaper)
ROE105.09%763.00% Weak
Net Margin-186.77%-45265.00% (disorted) Weak
Debt/Equity0.070.34 Strong (Low Leverage)
Current Ratio3.772795.60 Strong Liquidity
ROA-139.37%-16588.00% (disorted) Weak

CV outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews CapsoVision, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ